EdiTy Therapeutics
Rehovot, IL · Founded 2020 · 22 employees on LinkedIn · 2 known investors
Edity develops an AI-powered platform that engineers therapeutic proteins and uses immune cells (such as T-cells and NK cells) as carriers to deliver them to diseased tissues. Its plug-and-play technology is compatible with allogeneic approaches and aimed at creating new modalities for intracellular therapy.
Founders & leadership
EdiTy Therapeutics was founded in 2020 by Eyal Kolka and Michal Golan-Mashiach.
EK
Eyal KolkaCo-founder, Chairman of the Board
MG
Michal Golan-MashiachinFounder & CEO
Investors · 2
Founder mafia
3 people who came through EdiTy Therapeutics went on to found or lead other companies.
Frequently asked questions
- What does EdiTy Therapeutics do?
- Edity develops an AI-powered platform that engineers therapeutic proteins and uses immune cells (such as T-cells and NK cells) as carriers to deliver them to diseased tissues. Its plug-and-play technology is compatible with allogeneic approaches and aimed at creating new modalities for intracellular therapy.
- Who founded EdiTy Therapeutics?
- EdiTy Therapeutics was founded by Eyal Kolka, Michal Golan-Mashiach in 2020.
- Who are EdiTy Therapeutics's investors?
- EdiTy Therapeutics's investors include NFX, Tal Ventures.
- Where is EdiTy Therapeutics headquartered?
- EdiTy Therapeutics is headquartered in Rehovot, IL.